UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The Lancet (British edition), ISSN 0140-6736, 05/2018, Volume 391, Issue 10133, pp. 1916 - 1926
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Prevalence | State Medicine | Artemether, Lumefantrine Drug Combination | Humans | Fluorenes - therapeutic use | Male | Ethanolamines - administration & dosage | Primaquine - administration & dosage | Incidence | Rural Population | Malaria, Falciparum - diagnosis | Malaria, Falciparum - epidemiology | Female | Fluorenes - administration & dosage | Drug Resistance | Malaria, Falciparum - drug therapy | Artemisinins - administration & dosage | Treatment Outcome | Antimalarials - therapeutic use | Artemisinins - therapeutic use | Antimalarials - administration & dosage | Mass Drug Administration - methods | Primaquine - therapeutic use | Myanmar - epidemiology | Ethanolamines - therapeutic use | Early Diagnosis | Drug Combinations | Plasmodium falciparum | Diagnosis | Malaria | Analysis | Intervention | Dihydroartemisinin | Vector-borne diseases | Medical research | Primaquine | Hot spots | Artemisinin | Parasites | Dosage | Medical diagnosis | Molecular chains | Surveys | Charities | Tuberculosis | Acquired immune deficiency syndrome--AIDS | Villages | Artemether | Histocompatibility antigen HLA | Adults | Diagnostic systems | Genotypes | Index Medicus | Abridged Index Medicus | Life Sciences | Human health and pathology | Santé publique et épidémiologie | Infectious diseases
Journal Article
BMC medicine, ISSN 1741-7015, 12/2018, Volume 16, Issue 1, pp. 215 - 215
Adherence | Low transmission | Effectiveness | Malaria | Mass drug administration | Elimination | Single low-dose primaquine | Coverage | Dihydroartemisinin-piperaquine | Safety | Prevention | Drugs | Disease transmission | Primaquine | Analysis | Dosage and administration | Research | Dihydroartemisinin | Intervention | Vector-borne diseases | Control methods | Systematic review | Infections | Parasites | Health care facilities | Adhesion | Evidence-based medicine | Tropical diseases | Studies | Randomization | Clusters | Drug dosages | Index Medicus | Medicin och hälsovetenskap
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 11/2018, Volume 67, Issue 11, pp. 1670 - 1676
malaria control | Comoros Islands | Plasmodium falciparum | PfK13 Kelch-propeller gene | artemisinin-based combination therapy | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Malaria, Falciparum - prevention & control | Humans | Child, Preschool | Infant | Male | Parasitemia - drug therapy | Mass Drug Administration | Young Adult | Malaria, Falciparum - mortality | Malaria, Falciparum - epidemiology | Adult | Female | Drug Therapy, Combination | Endemic Diseases - prevention & control | Parasitemia - epidemiology | Child | Treatment Outcome | Antimalarials - therapeutic use | Polymorphism, Genetic | Artemisinins - therapeutic use | Primaquine - therapeutic use | Adolescent | Comoros - epidemiology | DNA, Protozoan - genetics | Quinolines - therapeutic use | Index Medicus | and Commentaries
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 02/2018, Volume 2018, Issue 2, pp. CD008152 - CD008152
Malaria, Falciparum | Mefloquine | Malaria | Drugs for preventing malaria | Primaquine | Chloroquine | Pyrimethamine | Antimalarials | Drugs for prevention for people living in endemic areas | Quinine | Randomized Controlled Trials as Topic | Prevention | Plasmodium falciparum | Infectious disease | Blood disorders | Artemisinins | Time Factors | Child health | Glucosephosphate Dehydrogenase Deficiency | Sulfadoxine | Non‐Randomized Controlled Trials as Topic | Medicine General & Introductory Medical Sciences | Malaria: prevention | Drug Combinations | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Malaria, Falciparum - prevention & control | Humans | Artemisinins - administration & dosage | Sulfadoxine - administration & dosage | Chloroquine - therapeutic use | Plasmodium falciparum - drug effects | Primaquine - administration & dosage | Glucosephosphate Dehydrogenase Deficiency - diagnosis | Malaria, Falciparum - parasitology | Malaria, Falciparum - transmission | Quinine - therapeutic use | Primaquine - analogs & derivatives | Artemisinins - therapeutic use | Mefloquine - therapeutic use | Antimalarials - administration & dosage | Pyrimethamine - administration & dosage | Mefloquine - administration & dosage | Non-Randomized Controlled Trials as Topic | Adult | Chloroquine - administration & dosage | Child | Index Medicus
Journal Article
Scientific reports, ISSN 2045-2322, 12/2019, Volume 9, Issue 1, pp. 19060 - 11
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Geography | Antimalarials - adverse effects | Recurrence | Prevalence | Kenya - epidemiology | Humans | Risk Factors | Hemoglobins - metabolism | Antimalarials - therapeutic use | Antimalarials - pharmacology | Mass Drug Administration - adverse effects | Anemia - complications | Medication Adherence | Parasites - drug effects | Animals | Malaria - epidemiology | Primaquine - therapeutic use | Malaria - parasitology | Primaquine - pharmacology | Malaria - drug therapy | Primaquine - adverse effects | Islands | Malaria | Microscopy | Index Medicus | Medicin och hälsovetenskap
Journal Article
The New England journal of medicine, ISSN 0028-4793, 01/2019, Volume 380, Issue 3, pp. 215 - 228
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Humans | Aminoquinolines - administration & dosage | Male | Parasitemia - drug therapy | Secondary Prevention - methods | Primaquine - administration & dosage | Adult | Female | Drug Therapy, Combination | Antimalarials - adverse effects | Double-Blind Method | Kaplan-Meier Estimate | Logistic Models | Malaria, Vivax - metabolism | Disease-Free Survival | Antimalarials - administration & dosage | Malaria, Vivax - drug therapy | Adolescent | Intention to Treat Analysis | Plasmodium vivax - isolation & purification | Cytochrome P-450 CYP2D6 - metabolism | Glucosephosphate Dehydrogenase - metabolism | Chloroquine - administration & dosage | Hemoglobins - analysis | Aminoquinolines - adverse effects | Prevention | Tafenoquine | Plasmodium vivax | Malaria | Analysis | Hemoglobin | Dosage and administration | Research | Drug therapy | Risk factors | Primaquine | Chloroquine | Liver | Clinical trials | Parasites | FDA approval | Patients | Evidence-based medicine | Manuscripts | Disease prevention | Glucose dehydrogenase | Glucosephosphate dehydrogenase | Parasitemia | Drug dosages | Pharmaceuticals | Index Medicus | Abridged Index Medicus
Journal Article
Journal of antimicrobial chemotherapy, ISSN 0305-7453, 2016, Volume 71, Issue 9, pp. 2405 - 2413
Pharmacology & Pharmacy | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Administration, Intravenous | Pneumocystis carinii - drug effects | Pneumonia, Pneumocystis - drug therapy | Trimethoprim, Sulfamethoxazole Drug Combination - administration & dosage | Clindamycin - administration & dosage | Humans | Hematologic Neoplasms - complications | Antifungal Agents - administration & dosage | Primaquine - administration & dosage | Index Medicus | Medicin och hälsovetenskap
Journal Article